Hard work from you and many valid points here. Despite the fact...

Hard work from you and many valid points here. Despite the fact we cannot prove BOD are acting in the best interest of Pfizer, it will be naive to believe they are same as before
Back to years ago, if the algo fail to reach threshold, conference call will be called immediately to restore investor confidence, the wording of Ann will be encouraging and inspiring, did they do anything this time?
In last TK’s speech there’s no mention about coming sleep check FDA update, something he would be very proudly gushing over in the past;

The Pfizer offer range difference 6.1c(20.7-14.6) compared to rest of resapp product is an insult of Covid screening market potential. while valuation can only be based on the rest of resapp commercialization and certificate, they came in and try to steal RAP Covid screening potential for free.

After the scheme is voted out next month, they not gonna walk away let others have chance to deal with RAP for Covid trail agreement which they eyed for 8 months. Possibly they will sign agreement with Covid screening business which is blue sky future. The devil has set foot here, he will get back what he wanted, only at cost. We just have to wait for possible FDA or other imminent good news (push SP north of 14c), if not vote no, and before they enter into something ridiculous again, have a serous conversation with BOD

One thing I firmly believe that without Pfizer, RAP with or without partner, can get Covid trail over the line - a copy of Resappdx but a different level of monster, as some said before, Resapp Covid Check won’t need a sales at all. We can have partner for commercialization, but just don’t want to give it away before getting certified.